Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

NCT02589457

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Chungnam National University Hospital Daejeon, Jung-gu, South Korea

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

NCT01724086

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Antwerp, Belgium

Bruges, Belgium

Brussels, Belgium

Edegem, Belgium

View Trial Details

Completed

Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients

NCT02646163

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Farabi General Hospital Dhaka, Bangladesh

View Trial Details

Completed

Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

NCT02646189

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Farabi General Hospital Dhaka, Bangladesh

View Trial Details

Completed

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

NCT01842451

Conditions: Blood-Borne Infections, CHC, Chronic Disease, +17 more
Locations: New Zealand Auckland, New Zealand

New Zealand Christchurch, New Zealand

View Trial Details

Completed

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

NCT01013272

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: The University of Hong Kong Hong Kong, China

View Trial Details

Completed

Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

NCT00723645

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

NCT01928147

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Investigational site Phoenix, Mauritius

Investigational site London, United Kingdom

Investigational site London, United Kingdom

Investigational site London, United Kingdom

View Trial Details

Completed

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

NCT01859962

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Quest Clinical Research San Francisco, California, United States

View Trial Details

Completed

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

NCT01830127

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1241.30.10003 Boehringer Ingelheim Investigational Site La Mesa, California, United States

1241.30.10007 Boehringer Ingelheim Investigational Site San Diego, California, United States

1241.30.10001 Boehringer Ingelheim Investigational Site DeLand, Florida, United States

1241.30.10012 Boehringer Ingelheim Investigational Site West Palm Beach, Florida, United States

View all 19 locations

View Trial Details